Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Extracellular Vesicles from Thyroid Carcinoma: The New Frontier of Liquid Biopsy.

Rappa G, Puglisi C, Santos MF, Forte S, Memeo L, Lorico A.

Int J Mol Sci. 2019 Mar 5;20(5). pii: E1114. doi: 10.3390/ijms20051114. Review.

2.

Unique Osteoid Osteoma of the Frontal Sinus From the Late Roman Empire.

Varotto E, Magro MT, Brancato R, Lubritto C, Memeo L, Galassi FM.

J Craniofac Surg. 2019 Jun;30(4):965-966. doi: 10.1097/SCS.0000000000005312. No abstract available.

PMID:
30817534
3.

In Vivo Evaluation of Biocompatibility and Chondrogenic Potential of a Cell-Free Collagen-Based Scaffold.

Calabrese G, Gulino R, Giuffrida R, Forte S, Figallo E, Fabbi C, Salvatorelli L, Memeo L, Gulisano M, Parenti R.

Front Physiol. 2017 Nov 29;8:984. doi: 10.3389/fphys.2017.00984. eCollection 2017.

4.

Cancer Targeted Therapy Strategy: The Pathologist's Perspectives.

Alessandrini L, Perin T, Kadare S, Del Pup L, Memeo L, Steffan A, Colarossi L, Berretta M, De Paoli P, Canzonieri V.

Curr Cancer Drug Targets. 2018;18(5):410-420. doi: 10.2174/1568009618666171129145703. Review.

PMID:
29189158
5.

Human adipose-derived mesenchymal stem cells seeded into a collagen-hydroxyapatite scaffold promote bone augmentation after implantation in the mouse.

Calabrese G, Giuffrida R, Forte S, Fabbi C, Figallo E, Salvatorelli L, Memeo L, Parenti R, Gulisano M, Gulino R.

Sci Rep. 2017 Aug 2;7(1):7110. doi: 10.1038/s41598-017-07672-0.

6.

Eribulin efficacy based on type of metastatic site: a real-life study in heavily pretreated metastatic breast cancer.

Prestifilippo A, Grippaldi D, Blanco G, Memeo L, Puliafito I, Giuffrida D.

Future Oncol. 2017 Apr;13(11s):5-10. doi: 10.2217/fon-2017-0017.

PMID:
28481186
7.

Effect of trehalose on cryopreservation of pure peripheral blood stem cells.

Martinetti D, Colarossi C, Buccheri S, Denti G, Memeo L, Vicari L.

Biomed Rep. 2017 Mar;6(3):314-318. doi: 10.3892/br.2017.859. Epub 2017 Feb 14.

8.

Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth.

Bellavia D, Raimondo S, Calabrese G, Forte S, Cristaldi M, Patinella A, Memeo L, Manno M, Raccosta S, Diana P, Cirrincione G, Giavaresi G, Monteleone F, Fontana S, De Leo G, Alessandro R.

Theranostics. 2017 Mar 16;7(5):1333-1345. doi: 10.7150/thno.17092. eCollection 2017.

9.

MicroRNA-based molecular classification of papillary thyroid carcinoma.

Rosignolo F, Memeo L, Monzani F, Colarossi C, Pecce V, Verrienti A, Durante C, Grani G, Lamartina L, Forte S, Martinetti D, Giuffrida D, Russo D, Basolo F, Filetti S, Sponziello M.

Int J Oncol. 2017 May;50(5):1767-1777. doi: 10.3892/ijo.2017.3960. Epub 2017 Apr 7.

PMID:
28393181
10.

Combination of Collagen-Based Scaffold and Bioactive Factors Induces Adipose-Derived Mesenchymal Stem Cells Chondrogenic Differentiation In vitro.

Calabrese G, Forte S, Gulino R, Cefalì F, Figallo E, Salvatorelli L, Maniscalchi ET, Angelico G, Parenti R, Gulisano M, Memeo L, Giuffrida R.

Front Physiol. 2017 Feb 2;8:50. doi: 10.3389/fphys.2017.00050. eCollection 2017.

11.

Bone augmentation after ectopic implantation of a cell-free collagen-hydroxyapatite scaffold in the mouse.

Calabrese G, Giuffrida R, Forte S, Salvatorelli L, Fabbi C, Figallo E, Gulisano M, Parenti R, Magro G, Colarossi C, Memeo L, Gulino R.

Sci Rep. 2016 Nov 8;6:36399. doi: 10.1038/srep36399.

12.

Differential expression of two activating transcription factor 5 isoforms in papillary thyroid carcinoma.

Vicari L, La Rosa C, Forte S, Calabrese G, Colarossi C, Aiello E, Salluzzo S, Memeo L.

Onco Targets Ther. 2016 Oct 11;9:6225-6231. eCollection 2016.

13.

Cancer stem cells as a potential therapeutic target in thyroid carcinoma.

Vicari L, Colarossi C, Giuffrida D, De Maria R, Memeo L.

Oncol Lett. 2016 Oct;12(4):2254-2260. Epub 2016 Aug 2.

14.

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.

She QB, Gruvberger-Saal SK, Maurer M, Chen Y, Jumppanen M, Su T, Dendy M, Lau YK, Memeo L, Horlings HM, van de Vijver MJ, Isola J, Hibshoosh H, Rosen N, Parsons R, Saal LH.

BMC Cancer. 2016 Aug 2;16:587. doi: 10.1186/s12885-016-2609-2.

15.

Resistance of papillary thyroid cancer stem cells to chemotherapy.

Giuffrida R, Adamo L, Iannolo G, Vicari L, Giuffrida D, Eramo A, Gulisano M, Memeo L, Conticello C.

Oncol Lett. 2016 Jul;12(1):687-691. Epub 2016 Jun 1.

16.

Collagen-Hydroxyapatite Scaffolds Induce Human Adipose Derived Stem Cells Osteogenic Differentiation In Vitro.

Calabrese G, Giuffrida R, Fabbi C, Figallo E, Lo Furno D, Gulino R, Colarossi C, Fullone F, Giuffrida R, Parenti R, Memeo L, Forte S.

PLoS One. 2016 Mar 16;11(3):e0151181. doi: 10.1371/journal.pone.0151181. eCollection 2016.

17.

Potential Role of Activating Transcription Factor 5 during Osteogenesis.

Vicari L, Calabrese G, Forte S, Giuffrida R, Colarossi C, Parrinello NL, Memeo L.

Stem Cells Int. 2016;2016:5282185. doi: 10.1155/2016/5282185. Epub 2015 Dec 6.

18.

Potential Effect of CD271 on Human Mesenchymal Stromal Cell Proliferation and Differentiation.

Calabrese G, Giuffrida R, Lo Furno D, Parrinello NL, Forte S, Gulino R, Colarossi C, Schinocca LR, Giuffrida R, Cardile V, Memeo L.

Int J Mol Sci. 2015 Jul 9;16(7):15609-24. doi: 10.3390/ijms160715609.

19.

Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.

Narayanan KB, Ali M, Barclay BJ, Cheng QS, D'Abronzo L, Dornetshuber-Fleiss R, Ghosh PM, Gonzalez Guzman MJ, Lee TJ, Leung PS, Li L, Luanpitpong S, Ratovitski E, Rojanasakul Y, Romano MF, Romano S, Sinha RK, Yedjou C, Al-Mulla F, Al-Temaimi R, Amedei A, Brown DG, Ryan EP, Colacci A, Hamid RA, Mondello C, Raju J, Salem HK, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Kim SY, Bisson WH, Lowe L, Park HH.

Carcinogenesis. 2015 Jun;36 Suppl 1:S89-110. doi: 10.1093/carcin/bgv032. Review.

20.

Causes of genome instability: the effect of low dose chemical exposures in modern society.

Langie SA, Koppen G, Desaulniers D, Al-Mulla F, Al-Temaimi R, Amedei A, Azqueta A, Bisson WH, Brown DG, Brunborg G, Charles AK, Chen T, Colacci A, Darroudi F, Forte S, Gonzalez L, Hamid RA, Knudsen LE, Leyns L, Lopez de Cerain Salsamendi A, Memeo L, Mondello C, Mothersill C, Olsen AK, Pavanello S, Raju J, Rojas E, Roy R, Ryan EP, Ostrosky-Wegman P, Salem HK, Scovassi AI, Singh N, Vaccari M, Van Schooten FJ, Valverde M, Woodrick J, Zhang L, van Larebeke N, Kirsch-Volders M, Collins AR.

Carcinogenesis. 2015 Jun;36 Suppl 1:S61-88. doi: 10.1093/carcin/bgv031. Review.

21.

The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.

Engström W, Darbre P, Eriksson S, Gulliver L, Hultman T, Karamouzis MV, Klaunig JE, Mehta R, Moorwood K, Sanderson T, Sone H, Vadgama P, Wagemaker G, Ward A, Singh N, Al-Mulla F, Al-Temaimi R, Amedei A, Colacci AM, Vaccari M, Mondello C, Scovassi AI, Raju J, Hamid RA, Memeo L, Forte S, Roy R, Woodrick J, Salem HK, Ryan EP, Brown DG, Bisson WH.

Carcinogenesis. 2015 Jun;36 Suppl 1:S38-60. doi: 10.1093/carcin/bgv030. Review.

22.

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.

Goodson WH 3rd, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C, Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F, Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami GN, Calaf GM, Williams G, Wolf GT, Koppen G, Brunborg G, Lyerly HK, Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH, Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondráček J, Raju J, Roman J, Wise JP Sr, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-Leal JF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA, Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L, McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M, Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart ME, Xia M, Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N, Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky-Wegman P, Thompson PA, Dent P, Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB, Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R, Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, Abd Hamid R, Langie SA, Eltom SE, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA, Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T, Dormoy V, Odero-Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engström W, Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z.

Carcinogenesis. 2015 Jun;36 Suppl 1:S254-96. doi: 10.1093/carcin/bgv039. Review. Erratum in: Carcinogenesis. 2016 Mar;37(3):344.

23.

Environmental immune disruptors, inflammation and cancer risk.

Thompson PA, Khatami M, Baglole CJ, Sun J, Harris SA, Moon EY, Al-Mulla F, Al-Temaimi R, Brown DG, Colacci A, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Hamid RA, Lowe L, Guarnieri T, Bisson WH.

Carcinogenesis. 2015 Jun;36 Suppl 1:S232-53. doi: 10.1093/carcin/bgv038. Review.

24.

Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?

Robey RB, Weisz J, Kuemmerle NB, Salzberg AC, Berg A, Brown DG, Kubik L, Palorini R, Al-Mulla F, Al-Temaimi R, Colacci A, Mondello C, Raju J, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Hamid RA, Williams GP, Lowe L, Meyer J, Martin FL, Bisson WH, Chiaradonna F, Ryan EP.

Carcinogenesis. 2015 Jun;36 Suppl 1:S203-31. doi: 10.1093/carcin/bgv037. Review.

25.

Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.

Nahta R, Al-Mulla F, Al-Temaimi R, Amedei A, Andrade-Vieira R, Bay SN, Brown DG, Calaf GM, Castellino RC, Cohen-Solal KA, Colacci A, Cruickshanks N, Dent P, Di Fiore R, Forte S, Goldberg GS, Hamid RA, Krishnan H, Laird DW, Lasfar A, Marignani PA, Memeo L, Mondello C, Naus CC, Ponce-Cusi R, Raju J, Roy D, Roy R, Ryan EP, Salem HK, Scovassi AI, Singh N, Vaccari M, Vento R, Vondráček J, Wade M, Woodrick J, Bisson WH.

Carcinogenesis. 2015 Jun;36 Suppl 1:S2-18. doi: 10.1093/carcin/bgv028. Review.

26.

Disruptive chemicals, senescence and immortality.

Carnero A, Blanco-Aparicio C, Kondoh H, Lleonart ME, Martinez-Leal JF, Mondello C, Scovassi AI, Bisson WH, Amedei A, Roy R, Woodrick J, Colacci A, Vaccari M, Raju J, Al-Mulla F, Al-Temaimi R, Salem HK, Memeo L, Forte S, Singh N, Hamid RA, Ryan EP, Brown DG, Wise JP Sr, Wise SS, Yasaei H.

Carcinogenesis. 2015 Jun;36 Suppl 1:S19-37. doi: 10.1093/carcin/bgv029. Review.

27.

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis.

Hu Z, Brooks SA, Dormoy V, Hsu CW, Hsu HY, Lin LT, Massfelder T, Rathmell WK, Xia M, Al-Mulla F, Al-Temaimi R, Amedei A, Brown DG, Prudhomme KR, Colacci A, Hamid RA, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Lowe L, Jensen L, Bisson WH, Kleinstreuer N.

Carcinogenesis. 2015 Jun;36 Suppl 1:S184-202. doi: 10.1093/carcin/bgv036. Review.

28.

The effect of environmental chemicals on the tumor microenvironment.

Casey SC, Vaccari M, Al-Mulla F, Al-Temaimi R, Amedei A, Barcellos-Hoff MH, Brown DG, Chapellier M, Christopher J, Curran CS, Forte S, Hamid RA, Heneberg P, Koch DC, Krishnakumar PK, Laconi E, Maguer-Satta V, Marongiu F, Memeo L, Mondello C, Raju J, Roman J, Roy R, Ryan EP, Ryeom S, Salem HK, Scovassi AI, Singh N, Soucek L, Vermeulen L, Whitfield JR, Woodrick J, Colacci A, Bisson WH, Felsher DW.

Carcinogenesis. 2015 Jun;36 Suppl 1:S160-83. doi: 10.1093/carcin/bgv035. Review.

29.

The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis.

Ochieng J, Nangami GN, Ogunkua O, Miousse IR, Koturbash I, Odero-Marah V, McCawley LJ, Nangia-Makker P, Ahmed N, Luqmani Y, Chen Z, Papagerakis S, Wolf GT, Dong C, Zhou BP, Brown DG, Colacci AM, Hamid RA, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Al-Temaimi R, Al-Mulla F, Bisson WH, Eltom SE.

Carcinogenesis. 2015 Jun;36 Suppl 1:S128-59. doi: 10.1093/carcin/bgv034. Review.

30.

Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions.

Kravchenko J, Corsini E, Williams MA, Decker W, Manjili MH, Otsuki T, Singh N, Al-Mulla F, Al-Temaimi R, Amedei A, Colacci AM, Vaccari M, Mondello C, Scovassi AI, Raju J, Hamid RA, Memeo L, Forte S, Roy R, Woodrick J, Salem HK, Ryan EP, Brown DG, Bisson WH, Lowe L, Lyerly HK.

Carcinogenesis. 2015 Jun;36 Suppl 1:S111-27. doi: 10.1093/carcin/bgv033. Epub 2015 May 22. Review.

31.

Numb Expression Contributes to the Maintenance of an Undifferentiated State in Human Epidermis.

Iannolo G, Sciuto MR, Buccheri S, Colarossi C, De Maria R, Memeo L, Conaldi PG.

Cell Transplant. 2016;25(2):353-64. doi: 10.3727/096368915X688245. Epub 2015 May 20.

PMID:
25994834
32.

The role of microRNAs in thyroid carcinomas.

Forte S, La Rosa C, Pecce V, Rosignolo F, Memeo L.

Anticancer Res. 2015 Apr;35(4):2037-47. Review.

PMID:
25862858
33.

MicroRNA and pediatric tumors: Future perspectives.

Gulino R, Forte S, Parenti R, Memeo L, Gulisano M.

Acta Histochem. 2015 May-Jun;117(4-5):339-54. doi: 10.1016/j.acthis.2015.02.007. Epub 2015 Mar 9. Review.

PMID:
25765112
34.

KRAS and BRAF mutational status in colon cancer from Albanian patients.

Martinetti D, Costanzo R, Kadare S, Alimehmeti M, Colarossi C, Canzonieri V, Berretta M, Memeo L.

Diagn Pathol. 2014 Sep 30;9:187. doi: 10.1186/s13000-014-0187-7.

35.

Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells.

Colarossi L, Memeo L, Colarossi C, Aiello E, Iuppa A, Espina V, Liotta L, Mueller C.

Proteomics Clin Appl. 2014 Dec;8(11-12):924-31. doi: 10.1002/prca.201400058. Epub 2014 Oct 22.

PMID:
25091122
36.

Assessment of MAGE-A expression in resected non-small cell lung cancer in relation to clinicopathologic features and mutational status of EGFR and KRAS.

Ayyoub M, Memeo L, Alvarez-Fernández E, Colarossi C, Costanzo R, Aiello E, Martinetti D, Valmori D.

Cancer Immunol Res. 2014 Oct;2(10):943-8. doi: 10.1158/2326-6066.CIR-13-0211. Epub 2014 May 27.

37.

Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts.

Sette G, Fecchi K, Salvati V, Lotti F, Pilozzi E, Duranti E, Biffoni M, Pagliuca A, Martinetti D, Memeo L, Milella M, De Maria R, Eramo A.

J Exp Clin Cancer Res. 2013 Nov 16;32:91. doi: 10.1186/1756-9966-32-91.

38.

A juvenile case of conjunctival atypical nevus.

Colarossi C, Milazzo M, Paglierani M, Massi D, Memeo L, Canzonieri V.

Diagn Pathol. 2013 Apr 22;8:64. doi: 10.1186/1746-1596-8-64.

39.

Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report.

Colarossi C, Pino P, Giuffrida D, Aiello E, Costanzo R, Martinetti D, Memeo L.

Diagn Pathol. 2013 Feb 4;8:19. doi: 10.1186/1746-1596-8-19.

40.

EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential.

Sette G, Salvati V, Memeo L, Fecchi K, Colarossi C, Di Matteo P, Signore M, Biffoni M, D'Andrea V, De Antoni E, Canzonieri V, De Maria R, Eramo A.

PLoS One. 2012;7(10):e46891. doi: 10.1371/journal.pone.0046891. Epub 2012 Oct 8.

41.

BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.

Coppola V, Musumeci M, Patrizii M, Cannistraci A, Addario A, Maugeri-Saccà M, Biffoni M, Francescangeli F, Cordenonsi M, Piccolo S, Memeo L, Pagliuca A, Muto G, Zeuner A, De Maria R, Bonci D.

Oncogene. 2013 Apr 4;32(14):1843-53. doi: 10.1038/onc.2012.194. Epub 2012 May 21.

PMID:
22614007
42.

Exocrine and endocrine modulation in common gastric carcinoma.

Canzonieri V, Colarossi C, Del Col L, Perin T, Talamini R, Sigon R, Cannizzaro R, Aiello E, Buonadonna A, Italia F, Massi D, Carbone A, Memeo L.

Am J Clin Pathol. 2012 May;137(5):712-21. doi: 10.1309/AJCPM13KVNCZQBUV.

PMID:
22523208
43.

PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.

Tong GX, Memeo L, Colarossi C, Hamele-Bena D, Magi-Galluzzi C, Zhou M, Lagana SM, Harik L, Oliver-Krasinski JM, Mansukhani M, Falcone L, Hibshoosh H, O'Toole K.

Am J Surg Pathol. 2011 Oct;35(10):1473-83. doi: 10.1097/PAS.0b013e318227e2ee.

PMID:
21934480
44.

One-step preservation of phosphoproteins and tissue morphology at room temperature for diagnostic and research specimens.

Mueller C, Edmiston KH, Carpenter C, Gaffney E, Ryan C, Ward R, White S, Memeo L, Colarossi C, Petricoin EF 3rd, Liotta LA, Espina V.

PLoS One. 2011;6(8):e23780. doi: 10.1371/journal.pone.0023780. Epub 2011 Aug 17.

45.

Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.

Hamaï A, Duperrier-Amouriaux K, Pignon P, Raimbaud I, Memeo L, Colarossi C, Canzonieri V, Perin T, Classe JM, Campone M, Jézéquel P, Campion L, Ayyoub M, Valmori D.

PLoS One. 2011;6(6):e21129. doi: 10.1371/journal.pone.0021129. Epub 2011 Jun 17.

46.

Breast metastasis of primary colon cancer with micrometastasis in the axillary sentinel node: a metastasis that metastasized?

Perin T, Canzonieri V, Memeo L, Massarut S.

Diagn Pathol. 2011 May 28;6:45. doi: 10.1186/1746-1596-6-45.

47.

Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer.

Musumeci M, Coppola V, Addario A, Patrizii M, Maugeri-Saccà M, Memeo L, Colarossi C, Francescangeli F, Biffoni M, Collura D, Giacobbe A, D'Urso L, Falchi M, Venneri MA, Muto G, De Maria R, Bonci D.

Oncogene. 2011 Oct 13;30(41):4231-42. doi: 10.1038/onc.2011.140. Epub 2011 May 2.

PMID:
21532615
48.

Expression of MAGE-A antigens is frequent in triple-negative breast cancers but does not correlate with that of basal-like markers.

Hamaï A, Memeo L, Colarossi C, Canzonieri V, Perin T, Ayyoub M, Valmori D.

Ann Oncol. 2011 Apr;22(4):986-7. doi: 10.1093/annonc/mdr038. Epub 2011 Mar 1. No abstract available.

PMID:
21363876
49.

Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumors.

Mordukhovich I, Rossner P Jr, Terry MB, Santella R, Zhang YJ, Hibshoosh H, Memeo L, Mansukhani M, Long CM, Garbowski G, Agrawal M, Gaudet MM, Steck SE, Sagiv SK, Eng SM, Teitelbaum SL, Neugut AI, Conway-Dorsey K, Gammon MD.

Environ Health Perspect. 2010 Apr;118(4):511-8. doi: 10.1289/ehp.0901233. Epub 2009 Nov 18.

50.

3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.

Maurer M, Su T, Saal LH, Koujak S, Hopkins BD, Barkley CR, Wu J, Nandula S, Dutta B, Xie Y, Chin YR, Kim DI, Ferris JS, Gruvberger-Saal SK, Laakso M, Wang X, Memeo L, Rojtman A, Matos T, Yu JS, Cordon-Cardo C, Isola J, Terry MB, Toker A, Mills GB, Zhao JJ, Murty VV, Hibshoosh H, Parsons R.

Cancer Res. 2009 Aug 1;69(15):6299-306. doi: 10.1158/0008-5472.CAN-09-0820. Epub 2009 Jul 14.

Supplemental Content

Support Center